000			01878ngm a2200433 a 4500
001			HST5476
003			UkLoHST
006			m c
007			cr|cna|||a||||
007			vz|czazum
008			210904s2021 enk|||||||||||s|||v|eng d
028	5	0	_a5476 _bHenry Stewart Talks
035			_a(UkLoHST)4726
040			_aUkLoHST _beng _cUkLoHST
100	1		_aMachtejevas, Egidijus. _4spk
245	1	0	_aAdvantages of using monolithic silica gel columns in the pharma industry _h[electronic resource] : _bPart 2, Biomolecule separation / _cEgidijus Machtejevas.
246	3		_aAdvantages of using monolithic silica gel columns in the pharma industry. Part 2 of 2, Biomolecule separation
260			_aLondon : _bHenry Stewart Talks, _c2021.
300			_a1 online resource (1 streaming video file (29 min.) : _bcolor, sound).
490	1		_aThe biomedical & life sciences collection, _x2056-452X
500			_aAnimated audio-visual presentation with synchronized narration.
500			_aTitle from title frames.
505	0		_aContents: HPLC analysis -- Monolithic columns -- Pore structure of monolithic columns -- Advantages and applications of monolithic columns -- Monolithic column modifications -- Immobilization -- The Schiff base method -- Bioreactors.
506			_aAccess restricted to subscribers.
538			_aMode of access: World Wide Web.
650		0	_aLiquid chromatography.
650		0	_aPharmaceutical technology.
650		0	_aSeparation (Technology)
650		0	_aSilica.
650		2	_aBioreactors.
650		2	_aChromatography, High Pressure Liquid.
650		2	_aChromatography, Liquid.
650		2	_aPorosity.
650		2	_aSchiff Bases.
650		2	_aSilica Gel.
650		2	_aSilicon Dioxide _xchemistry.
830		0	_aHenry Stewart talks. _pBiomedical & life sciences collection.
856	4	0	_uhttps://hstalks.com/bs/4726/
999			_c75689 _d75689